TORONTO -- (MARKET WIRE) -- November 01, 2006 -- Generex Biotechnology Corporation (NASDAQ: GNBT), the leader in drug delivery for metabolic diseases through the inner lining of the mouth, announced today that Anna Gluskin, the Company’s President & Chief Executive Officer, will be presenting at the Rodman & Renshaw 8th Annual Healthcare Conference (www.rodmanandrenshaw.com/us06conference) at The New York Palace Hotel in New York City, November 6 - 8, 2006. Ms. Gluskin’s presentation is scheduled for 9:30 a.m. (EST) on Monday, November 6, 2006.
